The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971
Abstract
OBJECTIVES: The epidemiology of gastrointestinal neuroendocrine tumors (GI-NETs) is poorly understood. Recent analyses have suggested changes in the incidence and distribution of such tumors, but have generally used data sets containing small patient numbers. We aimed to define trends in the epidemiology of GI-NETs in England over a 36-year period. METHODS: We analyzed data from the national population-based cancer registry, which covers a population in excess of 50 million, over the period 1971-2006. RESULTS: In all, 10,324 cases of GI-NETs were identified. The overall incidence increased from 0.27 (per 100,000 per year) to 1.32 for men and from 0.35 to 1.33 for women. The anatomic distribution of tumors in the latest period analyzed was stomach 12%, small intestine 29%, appendix 38%, colon 13%, and rectum 8%. The largest absolute increase in incidence was seen in the appendix (from 0.03 to 0.41 in men; from 0.05 to 0.59 in women). The greatest relative increase was in gastric NETs, increasing 2,325% in men, and 4,746% in women. Overall, 48% of GI-NETs occurred in men. Sex-specific incidence rates for gastric, colonic, and rectal NETs are similar, whereas appendiceal lesions were more common in females, and small intestinal tumors in men. CONCLUSIONS: Large increases in the incidence of GI-NETs were observed, along with changes in anatomical distribution. Such changes may partly reflect changes in classification or improved detection through the increased use of endoscopy and imaging techniques. In view of the magnitude of these changes, particularly for gastric tumors, further studies to examine the underlying etiology of these changes are urgently indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
International Histological Classification of Tumours
Weller, R. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.6.692-d · Cited by 2,042
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Carcinoid TumorsAn analysis of 2837 cases
Godwin, J. D. (1975) · Cancer · doi:10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4 · Cited by 1,106
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Updated Population-Based Review of Carcinoid Tumors
Maggard, M. A., O??Connell, J. B., & Ko, C. Y. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000129342.67174.67 · Cited by 552
Klinkenberg-Knol, E. C., Nelis, F., Dent, J., Snel, P., Mitchell, B., Prichard, P., Lloyd, D., Havu, N., Frame, M. H., Romàn, J., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70135-1 · Cited by 534
Neuroendocrine tumor epidemiology: Contrasting Norway and North America
Hauso, O., Gustafsson, B. I., Kidd, M., Waldum, H. L., Drozdov, I., Chan, A. K. C., & Modlin, I. M. (2008) · Cancer · doi:10.1002/cncr.23883 · Cited by 505
Fynn, R. W. (1959) · PubMed · Cited by 502
Carcinoid Tumor of the Appendix: Treatment and Prognosis
Moertel, C. G., Weiland, L. H., Nagorney, D. M., & Dockerty, M. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172704 · Cited by 427
Studies on medical and population subjects.
Adelstein, A. M. (1976) · Cited by 408
Havu, N. (1986) · Digestion · doi:10.1159/000199381 · Cited by 374
Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r · Cited by 363
Konishi, T., Watanabe, T., Kishimoto, J., Kotake, K., Muto, T., & Nagawa, H. (2007) · Gut · doi:10.1136/gut.2006.109157 · Cited by 249
CARCINOID TUMOURS: Frequency in a Defined Population During a 12‐Year‐Period
Berge, T., & Linell, F. (1976) · Acta Pathologica Microbiologica Scandinavica Section A Pathology · doi:10.1111/j.1699-0463.1976.tb00122.x · Cited by 238
A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?
Modlin, I. M., Lye, K. D., & Kidd, M. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04027.x · Cited by 217
Carcinoid Tumors of the Appendix
Roggo, A., Wood, W. C., & Ottinger, L. W. (1993) · Annals of Surgery · doi:10.1097/00000658-199304000-00010 · Cited by 189
Larsson, H., Carlsson, E. I., Håkanson, R., Mattsson, H., Nilsson, G., Seensalu, R., Wallmark, B., & Sundler, F. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80066-0 · Cited by 136
Consequences of Long‐Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas
Jensen, R. T. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_378.x · Cited by 129
Survival From Malignant Digestive Endocrine Tumors in England and Wales: A Population-Based Study
Lepage, C., Rachet, B., & Coleman, M. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.006 · Cited by 124
Self-citationThe epidemiology of carcinoid tumours in England and Scotland
Newton, J. N., Swerdlow, A. J., Silva, I. D. S., Vessey, M., Grahame‐Smith, D., Primatesta, P., & Reynolds, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.424 · Cited by 102
Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–97
Levi, F., Te, V.-C., Randimbison, L., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1394 · Cited by 90
European disparities in malignant digestive endocrine tumours survival
Lepage, C., Ciccolallo, L., Angelis, R. D., Bouvier, A., Faivre, J., Gatta, G., & The EUROCARE working group (2009) · International Journal of Cancer · doi:10.1002/ijc.24698 · Cited by 79
Gastric carcinoids: a temporal increase with proton pump introduction
Hodgson, N., Koniaris, L. G., Livingstone, A. S., & Franceschi, D. (2005) · Surgical Endoscopy · doi:10.1007/s00464-005-0232-4 · Cited by 76
Molecular Genetics of Neuroendocrine Tumors
Calender, A. (2000) · Digestion · doi:10.1159/000051850 · Cited by 71
Schenk, Kuipers, Klinkenberg‐Knol, Bloemena, E., Nelis, Festen, Jansen, J. B. �. �., Biemond, Lamers, & Meuwissen, S. G. M. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00349.x · Cited by 64
Kærlev, L., Teglbjaerg, P. S., Sabroe, S., Kolstad, H. A., Ahrens, W., Eriksson, M., Guénel, P., Gorini, G., Hardell, L., Cyr, D., et al. (2002) · Cancer Causes & Control · doi:10.1023/a:1013922226614 · Cited by 48
Omeprazole in oesophageal reflux disease
Dawson, R., & Manson, J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)71964-4 · Cited by 31
Walters, J. R. F. (2007) · Gut · doi:10.1136/gut.2006.107847 · Cited by 12
Cited by
Hallet, J., Law, C. H. L., Cukier, M., Saskin, R., Liu, N., & Singh, S. (2015) · Cancer · doi:10.1002/cncr.29099 · Cited by 852
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Pape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
Das, S., & Dasari, A. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01029-7 · Cited by 391
Metadata
- Authors
- Ellis, L., Shale, M. J., & Coleman, M. P.
- Venue
- American Journal of Gastroenterology
- Published
- 2010-12
- Volume
- 105
- Issue
- 12
- Pages
- 2563-2569
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2028133886
- Cited by
- 261
- References
- 33
- FWCI
- 9.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.